CY1113520T1 - Παραγωγα γλουταθειονης και χρησεις αυτων για θεραπεια ιικων νοσηματων - Google Patents

Παραγωγα γλουταθειονης και χρησεις αυτων για θεραπεια ιικων νοσηματων

Info

Publication number
CY1113520T1
CY1113520T1 CY20101101110T CY101101110T CY1113520T1 CY 1113520 T1 CY1113520 T1 CY 1113520T1 CY 20101101110 T CY20101101110 T CY 20101101110T CY 101101110 T CY101101110 T CY 101101110T CY 1113520 T1 CY1113520 T1 CY 1113520T1
Authority
CY
Cyprus
Prior art keywords
treatment
viral diseases
derivatives
glutathione derivatives
glutathione
Prior art date
Application number
CY20101101110T
Other languages
English (en)
Inventor
Umberto Benatti
Giorgio Brandi
Enrico Garaci
Mauro Magnani
Enrico Millo
Anna Teresa Palamara
Luigia Rossi
Original Assignee
First-Societa' A Responsabilita' Limitata Con Socio Unico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by First-Societa' A Responsabilita' Limitata Con Socio Unico filed Critical First-Societa' A Responsabilita' Limitata Con Socio Unico
Publication of CY1113520T1 publication Critical patent/CY1113520T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Παρέχονται παράγωγα γλουταθειόνης (GSH) του χημικού τύπου (I), όπου το R είναι προστατευτική θειολο-ομάδα. Τα παράγωγα είναι χρήσιμα στη θεραπεία λοιμώξεων από παραμυξοϊούς, ορθομυξοϊούς, απλό ιό του έρπητα και ιό του συνδρόμου επίκτητης ανοσοποιητικής ανεπάρκειας.
CY20101101110T 2003-12-30 2010-12-02 Παραγωγα γλουταθειονης και χρησεις αυτων για θεραπεια ιικων νοσηματων CY1113520T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001048A ITTO20031048A1 (it) 2003-12-30 2003-12-30 Derivati del glutatione e loro utilizzi per il trattamento di malattie virali.
EP04805051A EP1701973B1 (en) 2003-12-30 2004-12-29 Glutathione derivatives and their uses for the treatment of viral diseases

Publications (1)

Publication Number Publication Date
CY1113520T1 true CY1113520T1 (el) 2016-06-22

Family

ID=34717649

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101101110T CY1113520T1 (el) 2003-12-30 2010-12-02 Παραγωγα γλουταθειονης και χρησεις αυτων για θεραπεια ιικων νοσηματων

Country Status (12)

Country Link
US (2) US20070270349A1 (el)
EP (1) EP1701973B1 (el)
AT (1) ATE481413T1 (el)
CY (1) CY1113520T1 (el)
DE (1) DE602004029191D1 (el)
DK (1) DK1701973T3 (el)
ES (1) ES2352015T3 (el)
IT (1) ITTO20031048A1 (el)
PL (1) PL1701973T3 (el)
PT (1) PT1701973E (el)
SI (1) SI1701973T1 (el)
WO (1) WO2005063795A1 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1401504B1 (it) 2010-08-02 2013-07-26 Cattarini Mastelli Composizione comprendente glutatione reduttasi e glutatione ossidato
IT202100018602A1 (it) 2021-07-14 2023-01-14 Redox Co S R L Composto GSH-C4 per uso nel trattamento della psoriasi
CN117693352A (zh) * 2021-07-14 2024-03-12 瑞道克斯-科有限公司 针对气道疾病的谷胱甘肽c4
CN115386367B (zh) * 2022-08-17 2024-07-02 合江县公共检验检测中心 一种荧光纸质传感器
CN117257914B (zh) * 2023-11-03 2024-03-22 安徽农业大学 谷胱甘肽在制备预防或治疗家蚕核型多角体病毒病药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57134410A (en) * 1981-02-14 1982-08-19 Pola Chem Ind Inc Cosmetic
JPS632922A (ja) * 1986-06-20 1988-01-07 Yamanouchi Pharmaceut Co Ltd ドラツグキヤリア
US5464825A (en) * 1991-03-14 1995-11-07 Cornell Research Foundation, Inc. Raising glutathione equivalent levels using N-acyl glutathione monoesters
WO1998009986A1 (en) * 1996-09-02 1998-03-12 The Manchester Metropolitan University S-blocked glutathiones

Also Published As

Publication number Publication date
PL1701973T3 (pl) 2011-03-31
DE602004029191D1 (de) 2010-10-28
WO2005063795A1 (en) 2005-07-14
PT1701973E (pt) 2010-11-29
EP1701973A1 (en) 2006-09-20
EP1701973B1 (en) 2010-09-15
US20120165248A1 (en) 2012-06-28
ATE481413T1 (de) 2010-10-15
SI1701973T1 (sl) 2011-01-31
US20070270349A1 (en) 2007-11-22
ES2352015T3 (es) 2011-02-15
DK1701973T3 (da) 2011-01-10
ITTO20031048A1 (it) 2005-06-30

Similar Documents

Publication Publication Date Title
BR0316771A (pt) Compostos para o tratamento ou a prevenção de infecções por flavivirus, uso de um composto e composição farmacêutica
NO20051969L (no) Nukleosidderivater for behandling av hepatitt C virusinfeksjon.
ES2160046A1 (es) Derivados pentapeptidicos.
BR0305259A (pt) Inibidores de hcv ns5b polimerase
BRPI0411900B8 (pt) compostos e composições farmacêuticas compreendendo os mesmos
EP2041159B8 (en) Macrocyclic compounds as antiviral agents
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
NI200700102A (es) Derivados de indol tetraciclicos como agentes antiviricos
ATE373005T1 (de) Thienopyrrole als antivirale mittel
CY1113520T1 (el) Παραγωγα γλουταθειονης και χρησεις αυτων για θεραπεια ιικων νοσηματων
WO2005084192A3 (en) Novel 2’-c-methyl nucleoside derivatives
ECSP055801A (es) Compuestos benzofuránicos, composiciones y métodos para el tratamiento y profilaxis de infecciones virales de hepatitis c y enfermedades asociadas
NO20060979L (no) Nye tricykliske nukleosider eller nukleotider som terapeutiske midler
BR0305426A (pt) Compostos inibidores de ns5b polimerase de hcv, bem como composição farmacêutica compreendendo os mesmos
CY1110835T1 (el) Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c
CY1107626T1 (el) Παραγωγα πυραζολιου για την θεραπεια του hiv
WO2007029029A3 (en) Tetracyclic indole derivatives as antiviral agents
CL2004001161A1 (es) Compuestos describe compuestos derivados de quinolina; composicion farmaceutica; y su uso para tratar una enfermedad causada por el virus de la hepatitis c.
BRPI0415883A (pt) compostos e composições de nucleosìdeo para o tratamento de infecções virais
NO20065075L (no) Ikke-nukleosidbaserte revers-transkriptase-inhibitorer.
EA200600227A1 (ru) Замещённые арилтиомочевины, применимые в качестве ингибиторов репликации вирусов
BR0215016A (pt) Piridoquinoxalinas antivirìcas
DK1476467T3 (da) IgG3-immunglobulin som beskyttelsesmarkör mod virusinfektionssygdomme og anvendelser deraf
BRPI0519752A2 (pt) compostos peptÍdicos
WO2007076091A3 (en) Treatment of viral infections using a tissue factor inhibitor